Has Wei Yan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $400 in general payments to Wei Yan, MD across 19 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wei Yan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wei Yan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wei Yan, MD

Internal Medicine · Atlanta, GANPI 1598915019

Payments from drug & device makers

$400in general payments, 2019–2025

Across 19 payments — averaging $21.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$197
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$114
Gilead$27
Vifor Pharma, Inc.$23
Ferring Pharmaceuticals Inc.$21
Inari Medical, Inc.$19

What the payments were for

Food & beverage$400100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	10	$197
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$114
Gilead	1	$27
Vifor Pharma, Inc.	1	$23
Ferring Pharmaceuticals Inc.	1	$21
Inari Medical, Inc.	1	$19

How this compares

$400 in reported general payments places this provider in the 50th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia →

Medicare billing

Part B allowed, 2024

$132,259

Medicare patients

265

Services billed

1,162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	19	$11,716
Amlodipine Besylate	44	$226
Lisinopril	37	$208
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	22	$184
Atorvastatin Calcium	33	$181
Metoprolol Succinate	31	$174
Cefdinir	11	$168
Losartan Potassium	13	$112
ClopidogrelClopidogrel Bisulfate	19	$100
Tamsulosin Hcl	20	$94
Cephalexin	13	$79
Carvedilol	16	$75
Spironolactone	14	$61
Pantoprazole Sodium	11	$61
Azithromycin	13	$56

Paid to pharmacies, not to this prescriber.

Other internal medicine in Atlanta

Kimball JohnsonAtlanta$51.1M
Robert Springer IiiAtlanta$5.3M
Paulina Rebolledo EsteinouAtlanta$2.1M
Courtney SheltonAtlanta$1.2M
Melanie ThompsonAtlanta$1.1M
Tracey HenryAtlanta$305K
David WatsonAtlanta$286K
Priscilla Igho-PemuAtlanta$269K
Robert HerreraAtlanta$261K
Syed RahmanAtlanta$211K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →